U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Inspection References
  4. Nonclinical Laboratories Inspected under Good Laboratory Practices
  1. Inspection References

Nonclinical Laboratories Inspected under Good Laboratory Practices

Under the Federal Food, Drug and Cosmetic Act (FFDCA) and Public Health Service Act, the Food and Drug Administration (FDA) requires sponsors of most FDA-regulated products to submit evidence of their products’ safety in research and/or marketing applications.

The FDA conducts careful inspections of facilities that perform nonclinical laboratory studies to determine compliance with Part 58 (Good Laboratory Practice for Nonclinical Laboratory Studies) of Title 21 of the Code of Federal Regulations. Nonclinical laboratory studies are experiments in which test articles are studied prospectively in test systems (animals, plants, microorganisms, or subparts thereof) under laboratory conditions to determine their safety.

Please note: The information provided should not be used as a source to compile official counts. Requests for official counts of inspections should be directed to the FDA's Division of Freedom of Information.

Questions and comments regarding nonclinical inspections and the data can be directed by email to GLPQuestions@fda.hhs.gov

NonClinical Labs Inspected under GLP Data Sets

Archived Resources

Glossary



Back to Top